Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44526 - 44550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Fulvestrant	Approved Investigational	TFPI	7035	upregulated	fulvestrant results in increased expression of TFPI mRNA	2q32.1	A21106
Fulvestrant	Approved Investigational	TFRC	7037	upregulated	fulvestrant results in increased expression of TFRC mRNA	3q29	A20482
Fulvestrant	Approved Investigational	THBS2	7058	downregulated	fulvestrant results in decreased expression of THBS2 mRNA	6q27	A20479
Fulvestrant	Approved Investigational	TIMELESS	8914	downregulated	fulvestrant results in decreased expression of TIMELESS mRNA	12q13.3	A22729
Fulvestrant	Approved Investigational	TMPO	7112	downregulated	fulvestrant results in decreased expression of TMPO mRNA	12q23.1	A20479
Fulvestrant	Approved Investigational	TNPO1	3842	downregulated	fulvestrant results in decreased expression of TNPO1 mRNA	5q13.2	A20479
Fulvestrant	Approved Investigational	TOP1	7150	downregulated	fulvestrant results in decreased expression of TOP1 mRNA	20q12	A20479
Fulvestrant	Approved Investigational	TOP2A	7153	upregulated	fulvestrant results in increased expression of TOP2A mRNA	17q21.2	A20482
Fulvestrant	Approved Investigational	TOP2B	7155	downregulated	fulvestrant results in decreased expression of TOP2B mRNA	3p24.2	A20479
Fulvestrant	Approved Investigational	TRAK2	66008	downregulated	fulvestrant results in decreased expression of TRAK2 mRNA	2q33.1	A20479
Fulvestrant	Approved Investigational	TTK	7272	downregulated	fulvestrant results in decreased expression of TTK mRNA	6q14.1	A22729
Fulvestrant	Approved Investigational	TUBA1B	10376	upregulated	fulvestrant results in increased expression of TUBA1B mRNA	12q13.12	A20482
Fulvestrant	Approved Investigational	TXNRD1	7296	downregulated	fulvestrant results in decreased expression of TXNRD1 mRNA	12q23.3	A20479
Fulvestrant	Approved Investigational	UGT1A1	54658	upregulated	fulvestrant results in increased expression of UGT1A1 mRNA	2q37.1	A21102
Fulvestrant	Approved Investigational	UNG	7374	downregulated	fulvestrant results in decreased expression of UNG mRNA	12q24.11	A20479
Fulvestrant	Approved Investigational	USP32	84669	downregulated	fulvestrant results in decreased expression of USP32 mRNA	17q23.3	A20479
Fulvestrant	Approved Investigational	WNT2	7472	downregulated	fulvestrant results in decreased expression of WNT2 mRNA	7q31.2	A21102
Fulvestrant	Approved Investigational	WWC1	23286	downregulated	fulvestrant results in decreased expression of WWC1 mRNA	5q34	A21106
Fulvestrant	Approved Investigational	XPO1	7514	downregulated	fulvestrant results in decreased expression of XPO1 mRNA	2p15	A20479
Fulvestrant	Approved Investigational	XRCC5	7520	downregulated	fulvestrant results in decreased expression of XRCC5 mRNA	2q35	A20479
Fulvestrant	Approved Investigational	ZFX	7543	upregulated	fulvestrant results in increased expression of ZFX mRNA	Xp22.11	A20482
Fulvestrant	Approved Investigational	ZNF217	7764	upregulated	fulvestrant results in increased expression of ZNF217 mRNA	20q13.2	A21102
Fulvestrant	Approved Investigational	ZWINT	11130	downregulated	fulvestrant results in decreased expression of ZWINT mRNA	10q21-q22	A22729
Furazolidone	Investigational Vet Approved	CCND1	595	upregulated	Furazolidone results in increased expression of CCND1 mRNA	11q13.3	A22738 A22739
Furazolidone	Investigational Vet Approved	CCND3	896	upregulated	Furazolidone results in increased expression of CCND3 mRNA	6p21.1	A22738 A22739

Displaying entries 44526 - 44550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability